ADVERTISEMENT Watch CTV National News: How Trump suspending de minimis tariffs exemptions could affect Canadian business A local business owner shares her frustration after U.S. President Trump decides to remove de minimis exemptions. Genevieve Beauchemin reports.
A local business owner shares her frustration after U.S. President Trump decides to remove de minimis exemptions. Genevieve Beauchemin reports.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
17 minutes ago
- Global News
Rwanda reaches deal with U.S. to take upto 250 migrants, Reuters reports
The United States and Rwanda have agreed for the African country to potentially accept hundreds of migrants deported from the U.S., the spokesperson for the Rwandan government and an official told Reuters, as President Donald Trump's administration takes a hardline approach toward immigration. The agreement, under which Rwanda would accept up to 250 migrants, was signed by U.S. and Rwandan officials in Kigali in June, said the Rwandan official, speaking on condition of anonymity, adding that Washington had already sent an initial list of 10 people to be vetted. 'Rwanda has agreed with the United States to accept up to 250 migrants, in part because nearly every Rwandan family has experienced the hardships of displacement, and our societal values are founded on reintegration and rehabilitation,' said the spokesperson for the Rwandan government, Yolande Makolo. 'Under the agreement, Rwanda has the ability to approve each individual proposed for resettlement. Those approved will be provided with workforce training, healthcare, and accommodation support to jumpstart their lives in Rwanda, giving them the opportunity to contribute to one of the fastest-growing economies in the world over the last decade.' Story continues below advertisement The White House and State Department had no immediate comment. The Department of Homeland Security referred questions to the State Department. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy President Donald Trump aims to deport millions of immigrants in the U.S. illegally and his administration has sought to ramp up removals to third countries, including sending convicted criminals to South Sudan and Eswatini, formerly known as Swaziland. 2:36 Venezuela releases 10 jailed Americans in prisoner swap with El Salvador Rwanda has in recent years positioned itself as a destination country for migrants that Western countries would like to remove, despite concerns by rights groups that Kigali does not respect some of the most fundamental human rights. In May, the foreign minister said Rwanda was in the early stages of talks to receive immigrants deported from the United States. The Trump administration argues that third-country deportations help swiftly remove some migrants, including those with criminal convictions. Immigration hardliners see third-country removals as a way to deal with offenders who cannot easily be deported and could pose a threat to the public. Story continues below advertisement Opponents have criticized the deportations as dangerous and cruel, since people could be sent to countries where they could face violence, have no ties and do not speak the language. The Trump administration has pressed countries to take migrants. It deported more than 200 Venezuelans accused of being gang members to El Salvador in March, where they were jailed until they were released in a prisoner swap last month. The Supreme Court in June allowed the Trump administration to deport migrants to third countries without giving them a chance to show they could be harmed. But the legality of the removals is being contested in a federal lawsuit in Boston, a case that could potentially wind its way back to the conservative-leaning high court. Rwanda signed an agreement with Britain in 2022 to take in thousands of asylum seekers, a deal that was scrapped last year by then newly-elected Prime Minister Keir Starmer. No one was sent to Rwanda under the plan because of years of legal challenges.
Winnipeg Free Press
17 minutes ago
- Winnipeg Free Press
FACT FOCUS: Trump says he's cut drug prices by up to 1,500%. That's not possible
Days after he sent letters instructing top pharmaceutical manufacturers to use a 'most favored nation' pricing model for prescription drugs, President Donald Trump told reporters on Sunday that he had cut costs by up to 1,500%. But Trump's grandiose claim is mathematically impossible. Here's a closer look at the facts. TRUMP: 'You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500%. I don't mean 50%, I mean 14 — 1,500%.' THE FACTS: This is false. Cutting drug prices by more than 100% would theoretically mean that people are being paid to take medications. The Trump administration has taken steps to lower prescription drug prices, but experts say there's no indication costs have seen such a massive drop. Geoffrey Joyce, director of health policy at the University of Southern California's Schaeffer Center, called Trump's claim 'total fiction' made up by the Republican president. He agreed that it would amount to drug companies paying customers, rather than the other way around. 'I find it really difficult to translate those numbers into some actual estimates that patients would see at the pharmacy counter,' said Mariana Socal, an associate professor of health policy and management at Johns Hopkins University who studies the U.S. pharmaceutical market. She added that Trump's math is 'really hard to follow.' Asked what Trump was using to back up his claim, White House spokesman Kush Desai said: 'It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people.' The White House provided a chart of price differentials for drugs in the U.S. and comparable countries, but did not offer any other evidence. On Sunday, Trump also described cuts to drug prices as a future development, not that already happened. 'So we'll be dropping drug prices,' he said. 'It will start over the next two to three months by 1,200, 1,300 and even 1,400%.' Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than they are in other high-income countries. This is in large part due to the way drug prices are negotiated in the United States. Trump made his recent appeal in letters to 17 pharmaceutical manufacturers, the White House announced last week. He asked them to reduce costs in the U.S. by matching the lowest prices of prescriptions drugs in other comparably developed countries. Some drugmakers have since indicated that they are open to cutting costs. This move follows an executive order Trump signed in May setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits in the future over what the government will pay. The federal government has the most power to shape the price it pays for drugs covered by Medicare and Medicaid. It's unclear what — if any — impact the Trump administration's efforts will have on millions of Americans who have private health insurance. Socal pointed out that if drug manufacturers had cut costs to the extent Trump claims, they would be shouting it from the rooftops, especially given the heat they've taken over the years for their pricing practices. Wednesdays What's next in arts, life and pop culture. 'My expectation would be that they would make announcements — public announcements — and that those announcements would come way in advance of the actual effective dates when those price cuts would come into effect,' she said. Joyce agreed that there has been no indication of a substantial cut. 'Not at all, not at all, none whatsoever,' he said. 'And let alone 1,500.' ___ Find AP Fact Checks here:
Globe and Mail
17 minutes ago
- Globe and Mail
Millrose Properties, Inc. Announces Pricing of Upsized $1.25 Billion Senior Notes Offering
Millrose Properties, Inc. (NYSE: MRP) ('Millrose' or the 'Company') announced today the pricing of its private offering (the 'Offering') of $1.25 billion aggregate principal amount of its 6.375% Senior Notes due 2030 (the 'Notes'), representing a $250 million upsize from the previously announced offering size, at an initial offering price of 100.000% of the principal amount plus accrued interest, if any, from August 7, 2025. The Offering is expected to close on August 7, 2025, subject to customary closing conditions. Millrose intends to use the net proceeds of the Offering (i) to repay $500 million principal amount outstanding under the Company's term loan credit agreement, dated June 24, 2025 and maturing June 23, 2026, (ii) to repay $450 million principal amount of outstanding borrowings under the Company's revolving credit agreement dated February 7, 2025, and (iii) for general corporate purposes. The Notes and the related guarantee will be offered and sold only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended, (the 'Securities Act') and to certain non-U.S. persons in transactions outside the United States in reliance on Regulation S under the Securities Act. The Notes and the related guarantee have not been and will not be registered under the Securities Act or the securities laws of any state or other jurisdiction, and the Notes may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities or blue sky laws and foreign securities laws. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any securities, nor shall there be any sales of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This notice is being issued pursuant to and in accordance with Rule 135c under the Securities Act. About Millrose Properties, Inc. Millrose purchases and develops residential land and sells finished homesites to home builders by way of option contracts with predetermined costs and takedown schedules. Millrose serves as a solution for home builders seeking to expand access to finished homesites while implementing an asset-light strategy. As fully developed homesites are sold by Millrose, capital is recycled into future land acquisitions for home builders, providing customers with durable access to community growth. Forward-looking Statements Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute 'forward-looking statements' within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements about the Offering, the expected use of proceeds therefrom and other future events. All forward-looking statements included in this release are qualified in their entirety by, and should be read in the context of, the risk factors and other factors disclosed in the Company's filings with the Securities and Exchange Commission, which can be obtained free of charge on the Securities and Exchange Commission's web site at Except to the extent required by applicable law, Millrose undertakes no obligation to update or revise any information contained in this communication beyond the date hereof, whether as a result of new information, future events or otherwise.
